(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.

Clinical trial NCT00801723 · COMPLETED

Trial details

NCT number: NCT00801723
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2008-12-01
Primary completion: 2011-05-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.